MedPath

Effects of diet on the intestinal health of patients with liver fat

Not Applicable
Conditions
Fatty liver degeneration, not elsewhere classified
K76.0
Registration Number
RBR-2rcph2
Lead Sponsor
Faculdade de Medicina de Universidade Federal de Juiz de Fora
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age greater than 18 years; both genders; previous diagnosis of non-alcoholic steatohepatitis by means of liver biopsy.

Exclusion Criteria

Presence of chronic hepatitis B; chronic hepatitis C; autoimmune diseases of the liver; hemochromatosis; HIV-1 and 2-infected patients; patients with drug-induced; alcohol-induced liver disease (greater than 30 g / day in men or greater than 20 g / day in women); use of antibiotics in the two months prior to inclusion in the study.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Modulation of the fecal microbiota: result described in micro-gas density (x 108 g-1 cells), by fluorescent in situ hybridization technique <br><br>;Alteration of the bacterial overgrowth frequency in the small intestine: result expressed as a percentage and evaluated by respiratory test of exhaled hydrogen and methane.
Secondary Outcome Measures
NameTimeMethod
Changes in laboratory parameters: evaluation of hepatic transaminases, glycemic profile and lipid profile. Blood samples were collected and analyzed according to laboratory routine.;Change in anthropometric measurements and body composition: body weight, waist circumference, percentage of body fat and body mass index, by means of digital scale, tape measure and electric bioimpedance.
© Copyright 2025. All Rights Reserved by MedPath